Materialise SEC Filings

MTLS NASDAQ

Welcome to our dedicated page for Materialise SEC filings (Ticker: MTLS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

When you track a technology innovator like Materialise, you need more than a PDF download. Investors typically start by asking where the Medical, Software, and Manufacturing numbers sit or how many new surgical guides cleared regulators. Our page gathers every disclosure—from the expansive annual report (Materialise annual report 10-K simplified) to each Materialise 8-K material events explained alert—so you can find answers fast.

Open a filing and Stock Titan’s AI highlights what matters: segment revenue shifts, R&D outlays tied to new 3D-printing materials, and risk updates on EU medical-device rules. Use our dashboards to follow Materialise insider trading Form 4 transactions; real-time alerts surface each Materialise Form 4 insider transactions real-time entry before markets react. Quarterly updates? The latest Materialise quarterly earnings report 10-Q filing arrives seconds after EDGAR posts, paired with concise Materialise earnings report filing analysis that decodes margins and backlog trends.

Need deeper context? Our AI Q&A engine excels at understanding Materialise SEC documents with AI, guiding you to the footnote that explains additive-manufacturing capacity or the table detailing geographic sales. Quickly review the Materialise proxy statement executive compensation to see how leadership pay aligns with growth, or examine any Materialise executive stock transactions Form 4 for insight into management sentiment. With real-time updates, AI-powered summaries, and coverage of every form, Materialise SEC filings explained simply becomes more than a promise—it’s your new workflow.

07/24/2025 06:41 AM

Filing

[6-K] Materialise NV Current Report (Foreign Issuer)

Rhea-AI Summary

MTLS Q2-25 6-K highlights: Revenue €64.8 m, -5.8 % YoY; Medical +16.7 %, Software -12.1 %, Manufacturing -24.9 %. Gross profit €37.8 m, margin 58.3 % (+130 bps). Operating profit €2.7 m vs €3.8 m; net profit €0.2 m (EPS €0.00) vs €3.9 m, hurt by €3.1 m FX loss.

Adjusted EBIT €3.1 m (-21 %), margin 4.7 % (-90 bps). Adjusted EBITDA €8.3 m (-10 %), margin 12.8 %. Medical remains growth engine: adj EBITDA €10.7 m, margin 32.7 % (+360 bps). Manufacturing swung to a €0.8 m loss; Software flat.

Opex trimmed 0.8 % YoY; Q2 operating cash flow swung to –€0.03 m from €8.4 m. Cash & equivalents rose to €116.7 m; gross debt €53.7 m (vs €41.3 m), leaving net cash €63.0 m (+€2.0 m). Equity stable at €249.5 m.

No guidance provided. Strong Medical momentum and liquidity are offset by revenue contraction, FX headwinds and Manufacturing weakness.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-13.83%

[6-K] Materialise NV Current Report (Foreign Issuer)

Rhea-AI Summary

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-13.83%

FAQ

What is the current stock price of Materialise (MTLS)?

The current stock price of Materialise (MTLS) is $5.325 as of July 25, 2025.

What is the market cap of Materialise (MTLS)?

The market cap of Materialise (MTLS) is approximately 365.0M.

What are the main business segments of Materialise NV?

Materialise NV operates through three primary segments: the Medical segment, which focuses on medical software and device applications; the Software segment, dedicated to additive manufacturing solutions; and the Manufacturing segment, which provides fully integrated 3D printed products and services.

How does Materialise NV support the healthcare industry?

The company delivers advanced medical software solutions and 3D printing-enabled devices that enhance surgical planning, implant customization, and patient-specific treatment approaches, thus addressing complex healthcare challenges.

Which industries benefit from Materialise NV's technologies?

Materialise NV serves a range of sectors including healthcare, automotive, aerospace, consumer goods, and art and design, leveraging 3D printing and additive manufacturing to drive innovation and efficiency.

What role does additive manufacturing play in Materialise NV's operations?

Additive manufacturing is central to Materialise NV's solutions, enabling precise prototyping, customization, and scalable production. This technology underpins both its software and manufacturing segments, facilitating a seamless design-to-production workflow.

How does Materialise differentiate itself in the competitive 3D printing market?

Materialise distinguishes itself through a long history of innovation, a diversified business model, and an integrated approach that combines software excellence with advanced manufacturing processes, providing tailored solutions for varied industries.

What geographies does Materialise NV operate in?

The company maintains a global presence with operations in key markets across North America, numerous European countries, and the Asia Pacific, ensuring diverse regional representation and market adaptability.

How does Materialise NV ensure quality in its production processes?

Quality is maintained through state-of-the-art 3D printing technologies and rigorous workflow management systems that align with industry standards, ensuring reliable production and precision across all its business segments.

What technological advancements support Materialise NV's service offerings?

Materialise NV integrates advanced software tools that facilitate digital design, simulation, and production management. These technological innovations ensure efficient and tailored solutions across its medical, software, and manufacturing operations.